Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.60    -0.10 (-2.13%)
Bid:
4.56
Ask:
4.59
Spread: 0.03 (0.658%)
Market Cap: £220.78m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Automotive progress

18 Sep 2006 11:24

Seeing Machines Limited18 September 2006 18 September 2006 Seeing Machines Limited ("Seeing Machines" or the "Company") SEEING MACHINES MAKES STRONG PROGRESS IN AUTOMOTIVE MARKET DRIVER FATIGUE AND DISTRACTION SYSTEM COMMENCE SECOND PHASE FIELD TRIAL Seeing Machines (AIM : SEE) announce the commencement of the second phase fieldtrial of the driver fatigue, distraction and state sensor system ("DSS") inassociation with a major oil field services and mining company in Texas, USA.In a collaborative effort with our technology commercialization partner, HellaKGaA Hueck & Co ("Hella"), Seeing Machines is testing the technology under realworld operating conditions. This second phase trial builds on the initial phase that has been run over thelast 6 months with Seeing Machines' Texan Partners. That work has inspired anumber of refinements and optimizations of the DSS-Research product that are nowbeing tested. Nick Cerneaz, CEO, Seeing Machines said: "Putting the device into the hands of afleet operator working under such harsh conditions is allowing us to iron anyremaining issues before we proceed to the general release of the product in thenear future. We are enthused with the progress of the testing to date and verymuch look forward to this next phase." The DSS-Research Product will be released in Q4 2006 and is targeted atgovernment, university and fleet manager multi-car fleet trials / research. AutocRC PrOJECT Agreement SIGNED Seeing Machines announces the execution of an agreement for research,development and commercialisation into vision based collision avoidanceapplications with the Co-operative Research Centre for Advanced AutomotiveTechnology Ltd. ("AutoCRC"). Seeing Machines had earlier agreed to become aResearch Participant in the AutoCRC, and this agreement constitutes theformation of a specific project and programme of work within that framework. The vision based collision avoidance project is a collaborative project lead bySeeing Machines and includes Latrobe University and the Australian NationalUniversity as R&D participants along with GM Holden and Australian Arrow asindustry participants. Seeing Machines will receive A$788k for work on the project through to September2008. This project is initially focused on speed sign recognition, and throughthe remainder of the AutoCRC's seven year lifespan, additional funding may bemade available to address a range of other safety issues such as pedestriandetection and integrated lane departure warning. Nick Cerneaz, CEO, Seeing Machines said "The AutoCRC is a tremendous frameworkto support the development of advanced technology that requires contributionsfrom a wide spectrum of academic, technology and commercial partners, leveragingthe best each party has to offer. The computer vision based collision avoidancesystems being developed in this program dovetail nicely with the strategies ofour own automotive business and we are consequently keen supporters of thisprogramme." The AutoCRC was established as part of the Australian Federal Government's CRCProgram initiative. For more information on the CRC Program see https://www.crc.gov.au/Information/default.aspx. For more information on the AutoCRCsee www.autocrc.com. --- ENDS --- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713 www.seeingmachines.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.